home / stock / bntx / bntx news


BNTX News and Press, BioNTech SE From 04/19/23

Stock Information

Company Name: BioNTech SE
Stock Symbol: BNTX
Market: NYSE
Website: biontech.de

Menu

BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board
Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...

BNTX - Climbing A Wall Of Worry

2023-04-19 05:20:19 ET Summary We are now climbing a wall of worry in the stock market. How “Climbing a Wall of Worry” rallies end. How to invest from now until the end of the wall of worry. The stock market is often said to climb a wall of worry. This ...

BNTX - Ghana 1st in world to approve new malaria vaccine by Oxford

2023-04-14 05:32:00 ET Ghana became the first country globally to approve a new malaria vaccine developed by the Oxford University, BBC reported. Ghana's Food and Drugs Authority approved the vaccine, dubbed R21, for use in children between five months to three years old. The Africa...

BNTX - How the price action of Biontech Se ($BNTX) is used to our Advantage

2023-04-13 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BNTX - Appeals court permits limited access to abortion pill, blocks part of Texas ruling

2023-04-13 05:02:47 ET A federal appeals court blocked part of a Texas court's ruling that would halt the access to the abortion pill mifepristone. Earlier this week, the U.S. Justice Department (DOJ) had asked the U.S. 5th Circuit Court of Appeals to halt U.S. Judge Matthew Kacsmar...

BNTX - U.S. launches $5B program to speed up development of next-gen COVID vaccines

2023-04-10 22:25:44 ET The U.S. government is launching a $5B-plus program to accelerate the development of new coronavirus vaccines and treatments, officials from the Biden administration and the Department of Health and Human Services ( HHS ) confirmed Monday. An HHS official said...

BNTX - Week In Review: Suzhou Duality Out-Licenses 2 ADCs To BioNTech In $1.7 Billion Deal

2023-04-10 00:38:00 ET Summary Duality Biologics (Suzhou) out-licensed global rights (ex-China) for two ADC candidates to BioNTech in a deal worth $170 million upfront and up to $1.5 billion in milestone payments. Shanghai HutchMed has completed the rolling submission of a US NDA ...

BNTX - WHO chief expects COVID emergency to end this year

2023-04-06 14:14:11 ET After more than three years, the World Health Organization (WHO) could announce an end to the emergency status of COVID-19 this year, the head of the global body Dr. Tedros Adhanom Ghebreyesus, said Thursday. In early 2020, the WHO named the COVID-19 pandemic a Pu...

BNTX - Biontech Se $BNTX Trading Report

2023-04-04 08:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BNTX - Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech

Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP vaccines WARMINSTER, Pa., April 04, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus”), a clinical-stage biop...

BNTX - FDA poised to authorize second Omicron COVID boosters for some - WaPo

2023-04-03 18:44:09 ET In the next few weeks, the US FDA is likely to authorize a second booster shot specifically targeting COVID-19 Omicron variants for older individuals and those with weakened immune systems. The Washington Post reported that the goal is to provide those who...

Previous 10 Next 10